| October 4, 2007 |
| March 12, 2009 |
| July 2002 |
| July 2012 (final data collection date for primary outcome measure) |
| skin temperature during laser treatment [ Time Frame: 90 days ] [ Designated as safety issue: Yes ] |
| Same as current |
| Complete list of historical versions of study NCT00540917 on ClinicalTrials.gov Archive Site |
| |
| |
| |
| Measurement Skin Temperature During Pulsed Laser Exposure |
| Phase II Clinical Trial is to Compare Epidermal Temperature Measurements During 1.Laser Treatment at Standard Treatment Energies 2.Cryogen Spray Cooling (CSC) Plus Laser Treatment. 3.Contact Cooling Plus Laser Treatment. |
Lasers are the treatment modality of choice for Port Wine Stain birthmarks.The epidermis is not totally spared due to partial absorption of energy therein by melanin that presents an optical barrier through which the light must pass to reach the underlying blood vessels. Absorption of laser energy by melanin causes localized heating in the epidermis, which may, if not controlled, produce permanent complications such as hypertrophic scarring or dyspigmentation. |
The researchers want to establish a correlation between non-invasive skin temperature measurements and the minimum laser energy during skin laser treatment using cryogen spray cooling.
This study would eliminate the need for test pulses to estimate the safe and acceptable radiant exposure prior to laser treatment. |
| Phase II |
| Interventional |
| Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study |
| Port Wine Stain Birthmark |
| Procedure: cooling spray during laser treatment |
| Experimental: during laser treatment of portwine stain skin |
| |
| |
| Enrolling by invitation |
| 300 |
| July 2012 |
| July 2012 (final data collection date for primary outcome measure) |
Inclusion Criteria:
- 7 years of age and older with diagnosis of port wine stain birthmark
- 18 years of age and older with no port wine stain
- non-pregnant women
- apparent good health
Exclusion Criteria:
- age less than 7 years old
- pregnant women
- history of photodermatoses or skin cancer
- current use of photosensitizing drugs
|
| Both |
| 7 Years to 75 Years |
| Yes |
| Contact information is only displayed when the study is recruiting subjects |
| United States |
| |
| NCT00540917 |
| John S. Nelson, M.D., Ph.D, Beckman Laser Institute |
| CANDELAR can-44711, ASLMS-41746, LAMMP RR-01192-29 |
| University of California, Irvine |
- Beckman Laser Institute University of California Irvine
- Candela Corporation
|
| Principal Investigator: |
John S. Nelson, M.D., Ph.D |
Beckman Laser Institute University of California Irvine |
|
|
| University of California, Irvine |
| March 2009 |